During the last session, Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares were 0.55 million, with the beta value of the company hitting 0.18. At the end of the trading day, the stock’s price was $0.36, reflecting an intraday loss of -12.75% or -$0.05. The 52-week high for the REVB share is $25.26, that puts it down -6916.67 from that peak though still a striking -11.11% loss since the share price plummeted to a 52-week low of $0.40. The company’s market capitalization is $2.33M, and the average intraday trading volume over the past 10 days was 3.16 million shares, and the average trade volume was 995.82K shares over the past three months.
Revelation Biosciences Inc (REVB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. REVB has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.64.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Revelation Biosciences Inc (REVB) registered a -12.75% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -12.75% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is -18.18%, and it has moved by -60.44% in 30 days. Based on these gigs, the overall price performance for the year is -97.78%. The short interest in Revelation Biosciences Inc (NASDAQ:REVB) is 0.13 million shares and it means that shorts have 0.11 day(s) to cover.
Revelation Biosciences Inc (REVB) estimates and forecasts
Statistics show that Revelation Biosciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. Revelation Biosciences Inc (REVB) shares have gone down -83.71% during the last six months, with a year-to-date growth rate more than the industry average at 79.76% against 17.10.
While earnings are projected to return -1311.32% in 2024.
REVB Dividends
Revelation Biosciences Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Revelation Biosciences Inc insiders own 0.12% of total outstanding shares while institutional holders control 2.31%, with the float percentage being 2.31%.
